LogiTag Medical Solutions Ltd. – Trademark Portfolio
Entity Type: 99
LogiTag Medical Solutions Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SNAP & GO. The owner is based in Netanya.
29 Yad Harutzhim St., Building 9,
Poleg Industrial Zone, P.O. Box 8249
Netanya 42504 , IL
Showing of trademarks Trademarks
Trademark Classifications
LogiTag Medical Solutions Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LogiTag Medical Solutions Ltd. have?
LogiTag Medical Solutions Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does LogiTag Medical Solutions Ltd. file in?
LogiTag Medical Solutions Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LogiTag Medical Solutions Ltd.'s most well-known trademarks?
LogiTag Medical Solutions Ltd.'s registered trademark portfolio includes well-known marks such as SNAP & GO. These are among 1 currently registered trademark in the portfolio.
What is LogiTag Medical Solutions Ltd.'s trademark registration success rate?
LogiTag Medical Solutions Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.